Cargando…
Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial)
BACKGROUND: Research priorities in Antimicrobial Stewardship (AMS) have rapidly evolved in the last decade. The need for a more efficient use of antimicrobials have fueled plenty of studies to define the optimal duration for antibiotic treatments, and yet, there still are large areas of uncertainty...
Autores principales: | Molina, José, Rosso-Fernández, Clara María, Montero-Mateos, Enrique, Paño-Pardo, José Ramón, Solla, María, Guisado-Gil, Ana Belén, Álvarez-Marín, Rocío, Pachón-Ibáñez, María Eugenia, Gimeno, Adelina, Martín-Gutiérrez, Guillermo, Lepe, José Antonio, Cisneros, José Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778939/ https://www.ncbi.nlm.nih.gov/pubmed/36548225 http://dx.doi.org/10.1371/journal.pone.0277333 |
Ejemplares similares
-
Safety of early oral ambulatory treatment of adult patients with bloodstream infections discharged from the emergency department
por: Casado, Ana, et al.
Publicado: (2023) -
Prevalence and Risk Factors for Multidrug-Resistant Organisms Colonization in Long-Term Care Facilities Around the World: A Review
por: Rodríguez-Villodres, Ángel, et al.
Publicado: (2021) -
Impact of the COVID-19 Pandemic on Antimicrobial Consumption and Hospital-Acquired Candidemia and Multidrug-Resistant Bloodstream Infections
por: Guisado-Gil, Ana Belen, et al.
Publicado: (2020) -
IgM-enriched immunoglobulin improves colistin efficacy in a pneumonia model by Pseudomonas aeruginosa
por: Cebrero-Cangueiro, Tania, et al.
Publicado: (2022) -
Carbapenem Combinations for Infections Caused by Carbapenemase-Producing Pseudomonas aeruginosa: Experimental In Vitro and In Vivo Analysis
por: Herrera-Espejo, Soraya, et al.
Publicado: (2022)